These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20417766)

  • 1. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S
    Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprotinin during coronary-artery bypass grafting and risk of death.
    Schneeweiss S; Seeger JD; Landon J; Walker AM
    N Engl J Med; 2008 Feb; 358(8):771-83. PubMed ID: 18287600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G; Sartipy U; Ivert T; van der Linden J
    Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival.
    Puskas JD; Kilgo PD; Lattouf OM; Thourani VH; Cooper WA; Vassiliades TA; Chen EP; Vega JD; Guyton RA
    Ann Thorac Surg; 2008 Oct; 86(4):1139-46; discussion 1146. PubMed ID: 18805149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.
    Chu D; Bakaeen FG; Wang XL; Dao TK; LeMaire SA; Coselli JS; Huh J
    Ann Thorac Surg; 2008 Oct; 86(4):1175-80. PubMed ID: 18805156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF
    N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.
    Engoren M; Habib RH; Hadaway J; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Ann Thorac Surg; 2009 Jul; 88(1):95-100, 100.e1-3. PubMed ID: 19559202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy.
    Racz MJ; Hannan EL; Isom OW; Subramanian VA; Jones RH; Gold JP; Ryan TJ; Hartman A; Culliford AT; Bennett E; Lancey RA; Rose EA
    J Am Coll Cardiol; 2004 Feb; 43(4):557-64. PubMed ID: 14975463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cardiac surgery safe in extremely obese patients (body mass index 50 or greater)?
    Sun X; Hill PC; Bafi AS; Garcia JM; Haile E; Corso PJ; Boyce SW
    Ann Thorac Surg; 2009 Feb; 87(2):540-6. PubMed ID: 19161775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women have worse long-term outcomes after coronary artery bypass grafting than men.
    Hassan A; Chiasson M; Buth K; Hirsch G
    Can J Cardiol; 2005 Jul; 21(9):757-62. PubMed ID: 16082435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.